Vor Biopharma (VOR) Return on Equity [ROE] (2021 - 2025)
Vor Biopharma's Return on Equity [ROE] was -145.76% in Q1 2025, down 57.92 percentage points from -87.84% a year earlier and down 7.90 percentage points from the prior quarter.
Powered by 
Analysis
Vor Biopharma (VOR) Return on Equity [ROE] (2021 - 2025) Analysis & Trends
For FY2024, Return on Equity [ROE] at Vor Biopharma came in at -94.52%, down 35.78 percentage points from FY2023.
- Return on Equity [ROE] shows a three-year change of -6.86 percentage points (FY2021 to FY2024).
- In earlier years, Return on Equity [ROE] was -58.74% in FY2023 (-19.28 pp), -39.45% in FY2022 (+48.21 pp) and -87.66% in FY2021.
- The Q1 2025 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
- Compared with a year earlier, Return on Equity [ROE] has declined for 12 straight quarters, with an average year-over-year change of -42.56 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2022 (a gain of 9.35 percentage points); the worst was Q3 2024 (a drop of 70.59 percentage points).
- Per Business Quant data, VOR's Return on Equity [ROE] in the three quarters before Q1 2025 was -137.85% (Q4 2024), -131.51% (Q3 2024) and -106.82% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Vor Biopharma | 1.02 Bn | 1.02 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -145.76% |
| Dec 31, 2024 | -137.85% |
| Sep 30, 2024 | -131.51% |
| Jun 30, 2024 | -106.82% |
| Mar 31, 2024 | -87.84% |
| Dec 31, 2023 | -72.42% |
| Sep 30, 2023 | -60.92% |
| Jun 30, 2023 | -48.82% |
| Mar 31, 2023 | -40.68% |
| Dec 31, 2022 | -45.00% |
| Sep 30, 2022 | -51.80% |
| Jun 30, 2022 | -43.96% |
| Mar 31, 2022 | -37.94% |
| Dec 31, 2021 | -30.67% |
| Sep 30, 2021 | -27.45% |
| Jun 30, 2021 | -23.02% |
| Mar 31, 2021 | -47.29% |
API Access
Vor Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();